Brief: Aptorum Therapeutics Ltd Enters Into Letter Of Intent And Term Sheet With Universal Sequencing Technology Corp To Merge With Aptorum Group's Subsidiary Paths Innovations Ltd

May 1 (Reuters) - Aptorum Group Ltd  APM.O :
    * APTORUM THERAPEUTICS LIMITED ENTERS INTO LETTER OF INTENT
AND
TERM SHEET WITH UNIVERSAL SEQUENCING TECHNOLOGY CORPORATION TO
MERGE WITH APTORUM GROUP’S SUBSIDIARY PATHS INNOVATIONS LIMITED
    * APTORUM GROUP LTD-AS CONSIDERATION OF TRANSACTION UPON
CLOSING,
CO'S UNIT APTORUM THERAPEUTICS LIMITED WILL BECOME SHAREHOLDER
OF COMBINED CO

Source text for Eikon:  ID:nBw893cda 
Further company coverage:  APM.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aptorum

See all news